Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories
Authors:
- Leslie R. ZwerwerLZLeslie R. Zwerwer
- Covid-19 Infection Survey TeamCTCovid-19 Infection Survey Team
Preprint
Abstract
During the COVID-19 pandemic, numerous SARS-CoV-2 infections remained undetected. Serological testing could potentially aid their identification. We combined results from routine monthly nose and throat swabs, and self-reported positive swab tests, from a UK household survey, linked to national swab testing programme data from England and Wales, together with Nucleocapsid (N-) antibody trajectories clustered using a longitudinal variation of K-means to estimate the number of infections undetected by either approach (N=185,646). After combining N-antibody (hypothetical) infections with swab-positivity, we estimated that 7.4% of all true infections would have remained undetected, 25.8% by swab-positivity-only and 28.6% by trajectory-based N-antibody classifications only. Congruence with swab-positivity was much poorer using a fixed threshold to define N-antibody infections. Additionally, using multivariable logistic regression N-antibody seroconversion was more likely as age increased between 30 and 60 years, in non-white participants, those less (recently/frequently) vaccinated, for lower Ct values in the range above 30, in symptomatic and Delta (vs BA.1) infections. Comparing swab-positivity data sources showed that routine monthly swabs were not sufficient to detect infections by swab-positivity only and incorporating national testing programme/self-reported data substantially increased detection rates. Overall, whilst N-antibody serosurveillance can identify infections undetected by swab-positivity, optimal use requires trajectory-based analysis.Keywords
All Related Versions
- Published version: Nature Communications, 16 (1), 1.
This publication has 40 references indexed in Scilit:
- Proportion of asymptomatic infection and nonsevere disease caused by SARS‐CoV‐2 Omicron variant: A systematic review and analysisJournal of Medical Virology, 2022
- Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 StrainsJAMA Network Open, 2022
- Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community cohortInternational Journal of Infectious Diseases, 2022
- SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donorsEuropean Journal of Internal Medicine, 2021
- A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United StateseClinicalMedicine, 2021
- Back to normal; serological testing for COVID‐19 diagnosis unveils missed infectionsJournal of Medical Virology, 2021
- Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infectionJournal of Clinical Virology, 2021
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyCell, 2020
- Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAsClinical Microbiology and Infection, 2020
- Estimating the undetected infections in the Covid-19 outbreak by harnessing capture–recapture methodsInternational Journal of Infectious Diseases, 2020